685 ROUTE 202/206 N., SUITE 301, BRIDGEWATER, NJ
Amendment to Merger Agreement Between VYNE Therapeutics and Yarrow
Merger with Yarrow Bioscience
VYNE Therapeutics Inc. Annual Meeting Results - Director Elections Held
Annual Report to Security Holders
Reports 2025 Third Quarter Financial Results and Provides Business Update
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Reports 2025 Second Quarter Financial Results and Provides Business Update
Investor Presentation
FY 2024
Q3
Q2
Q1
S-4
Prospectus Filed Pursuant to Rule 425
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload